Report Detail

Pharma & Healthcare COVID-19 Impact on Global Orthobiologics Market Size, Status and Forecast 2020-2026

  • RnM4073905
  • |
  • 23 June, 2020
  • |
  • Global
  • |
  • 126 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

This report focuses on the global Orthobiologics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Orthobiologics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Medtronic
NuVasive, Inc.
Stryker Corporation
Zimmer Biomet Holdings
Orthofix International N.V.
Anika Therapeutics, Inc.
DePuy Synthes (Johnson & Johnson)
Bioventus
Arthrex, Inc.
SeaSpine Holdings Corporation
Sanofi-Aventis (Sanofi SA)
Djo Global, Inc.
Seikagaku Corporation
RTI Surgical, Inc.
Heraeus Holding GmbH
Fidia Pharma USA Inc.
TRB Chemedica International SA
Allosource
Musculoskeletal Transplant Foundation, Inc.
Ito

Market segment by Type, the product can be split into
Bone Growth Stimulators (BGS)
Viscosupplements
Bone Graft Substitute
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centres
Orthopaedics Clinics

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Orthobiologics status, future forecast, growth opportunity, key market and key players.
To present the Orthobiologics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Orthobiologics are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Orthobiologics Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Orthobiologics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Bone Growth Stimulators (BGS)
    • 1.4.3 Viscosupplements
    • 1.4.4 Bone Graft Substitute
  • 1.5 Market by Application
    • 1.5.1 Global Orthobiologics Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Ambulatory Surgical Centres
    • 1.5.4 Orthopaedics Clinics
  • 1.6 Coronavirus Disease 2019 (Covid-19): Orthobiologics Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Orthobiologics Industry
      • 1.6.1.1 Orthobiologics Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Orthobiologics Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Orthobiologics Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Orthobiologics Market Perspective (2015-2026)
  • 2.2 Orthobiologics Growth Trends by Regions
    • 2.2.1 Orthobiologics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Orthobiologics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Orthobiologics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Orthobiologics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Orthobiologics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Orthobiologics Players by Market Size
    • 3.1.1 Global Top Orthobiologics Players by Revenue (2015-2020)
    • 3.1.2 Global Orthobiologics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Orthobiologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Orthobiologics Market Concentration Ratio
    • 3.2.1 Global Orthobiologics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Orthobiologics Revenue in 2019
  • 3.3 Orthobiologics Key Players Head office and Area Served
  • 3.4 Key Players Orthobiologics Product Solution and Service
  • 3.5 Date of Enter into Orthobiologics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Orthobiologics Historic Market Size by Type (2015-2020)
  • 4.2 Global Orthobiologics Forecasted Market Size by Type (2021-2026)

5 Orthobiologics Breakdown Data by Application (2015-2026)

  • 5.1 Global Orthobiologics Market Size by Application (2015-2020)
  • 5.2 Global Orthobiologics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Orthobiologics Market Size (2015-2020)
  • 6.2 Orthobiologics Key Players in North America (2019-2020)
  • 6.3 North America Orthobiologics Market Size by Type (2015-2020)
  • 6.4 North America Orthobiologics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Orthobiologics Market Size (2015-2020)
  • 7.2 Orthobiologics Key Players in Europe (2019-2020)
  • 7.3 Europe Orthobiologics Market Size by Type (2015-2020)
  • 7.4 Europe Orthobiologics Market Size by Application (2015-2020)

8 China

  • 8.1 China Orthobiologics Market Size (2015-2020)
  • 8.2 Orthobiologics Key Players in China (2019-2020)
  • 8.3 China Orthobiologics Market Size by Type (2015-2020)
  • 8.4 China Orthobiologics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Orthobiologics Market Size (2015-2020)
  • 9.2 Orthobiologics Key Players in Japan (2019-2020)
  • 9.3 Japan Orthobiologics Market Size by Type (2015-2020)
  • 9.4 Japan Orthobiologics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Orthobiologics Market Size (2015-2020)
  • 10.2 Orthobiologics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Orthobiologics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Orthobiologics Market Size by Application (2015-2020)

11 India

  • 11.1 India Orthobiologics Market Size (2015-2020)
  • 11.2 Orthobiologics Key Players in India (2019-2020)
  • 11.3 India Orthobiologics Market Size by Type (2015-2020)
  • 11.4 India Orthobiologics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Orthobiologics Market Size (2015-2020)
  • 12.2 Orthobiologics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Orthobiologics Market Size by Type (2015-2020)
  • 12.4 Central & South America Orthobiologics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Medtronic
    • 13.1.1 Medtronic Company Details
    • 13.1.2 Medtronic Business Overview and Its Total Revenue
    • 13.1.3 Medtronic Orthobiologics Introduction
    • 13.1.4 Medtronic Revenue in Orthobiologics Business (2015-2020))
    • 13.1.5 Medtronic Recent Development
  • 13.2 NuVasive, Inc.
    • 13.2.1 NuVasive, Inc. Company Details
    • 13.2.2 NuVasive, Inc. Business Overview and Its Total Revenue
    • 13.2.3 NuVasive, Inc. Orthobiologics Introduction
    • 13.2.4 NuVasive, Inc. Revenue in Orthobiologics Business (2015-2020)
    • 13.2.5 NuVasive, Inc. Recent Development
  • 13.3 Stryker Corporation
    • 13.3.1 Stryker Corporation Company Details
    • 13.3.2 Stryker Corporation Business Overview and Its Total Revenue
    • 13.3.3 Stryker Corporation Orthobiologics Introduction
    • 13.3.4 Stryker Corporation Revenue in Orthobiologics Business (2015-2020)
    • 13.3.5 Stryker Corporation Recent Development
  • 13.4 Zimmer Biomet Holdings
    • 13.4.1 Zimmer Biomet Holdings Company Details
    • 13.4.2 Zimmer Biomet Holdings Business Overview and Its Total Revenue
    • 13.4.3 Zimmer Biomet Holdings Orthobiologics Introduction
    • 13.4.4 Zimmer Biomet Holdings Revenue in Orthobiologics Business (2015-2020)
    • 13.4.5 Zimmer Biomet Holdings Recent Development
  • 13.5 Orthofix International N.V.
    • 13.5.1 Orthofix International N.V. Company Details
    • 13.5.2 Orthofix International N.V. Business Overview and Its Total Revenue
    • 13.5.3 Orthofix International N.V. Orthobiologics Introduction
    • 13.5.4 Orthofix International N.V. Revenue in Orthobiologics Business (2015-2020)
    • 13.5.5 Orthofix International N.V. Recent Development
  • 13.6 Anika Therapeutics, Inc.
    • 13.6.1 Anika Therapeutics, Inc. Company Details
    • 13.6.2 Anika Therapeutics, Inc. Business Overview and Its Total Revenue
    • 13.6.3 Anika Therapeutics, Inc. Orthobiologics Introduction
    • 13.6.4 Anika Therapeutics, Inc. Revenue in Orthobiologics Business (2015-2020)
    • 13.6.5 Anika Therapeutics, Inc. Recent Development
  • 13.7 DePuy Synthes (Johnson & Johnson)
    • 13.7.1 DePuy Synthes (Johnson & Johnson) Company Details
    • 13.7.2 DePuy Synthes (Johnson & Johnson) Business Overview and Its Total Revenue
    • 13.7.3 DePuy Synthes (Johnson & Johnson) Orthobiologics Introduction
    • 13.7.4 DePuy Synthes (Johnson & Johnson) Revenue in Orthobiologics Business (2015-2020)
    • 13.7.5 DePuy Synthes (Johnson & Johnson) Recent Development
  • 13.8 Bioventus
    • 13.8.1 Bioventus Company Details
    • 13.8.2 Bioventus Business Overview and Its Total Revenue
    • 13.8.3 Bioventus Orthobiologics Introduction
    • 13.8.4 Bioventus Revenue in Orthobiologics Business (2015-2020)
    • 13.8.5 Bioventus Recent Development
  • 13.9 Arthrex, Inc.
    • 13.9.1 Arthrex, Inc. Company Details
    • 13.9.2 Arthrex, Inc. Business Overview and Its Total Revenue
    • 13.9.3 Arthrex, Inc. Orthobiologics Introduction
    • 13.9.4 Arthrex, Inc. Revenue in Orthobiologics Business (2015-2020)
    • 13.9.5 Arthrex, Inc. Recent Development
  • 13.10 SeaSpine Holdings Corporation
    • 13.10.1 SeaSpine Holdings Corporation Company Details
    • 13.10.2 SeaSpine Holdings Corporation Business Overview and Its Total Revenue
    • 13.10.3 SeaSpine Holdings Corporation Orthobiologics Introduction
    • 13.10.4 SeaSpine Holdings Corporation Revenue in Orthobiologics Business (2015-2020)
    • 13.10.5 SeaSpine Holdings Corporation Recent Development
  • 13.11 Sanofi-Aventis (Sanofi SA)
    • 10.11.1 Sanofi-Aventis (Sanofi SA) Company Details
    • 10.11.2 Sanofi-Aventis (Sanofi SA) Business Overview and Its Total Revenue
    • 10.11.3 Sanofi-Aventis (Sanofi SA) Orthobiologics Introduction
    • 10.11.4 Sanofi-Aventis (Sanofi SA) Revenue in Orthobiologics Business (2015-2020)
    • 10.11.5 Sanofi-Aventis (Sanofi SA) Recent Development
  • 13.12 Djo Global, Inc.
    • 10.12.1 Djo Global, Inc. Company Details
    • 10.12.2 Djo Global, Inc. Business Overview and Its Total Revenue
    • 10.12.3 Djo Global, Inc. Orthobiologics Introduction
    • 10.12.4 Djo Global, Inc. Revenue in Orthobiologics Business (2015-2020)
    • 10.12.5 Djo Global, Inc. Recent Development
  • 13.13 Seikagaku Corporation
    • 10.13.1 Seikagaku Corporation Company Details
    • 10.13.2 Seikagaku Corporation Business Overview and Its Total Revenue
    • 10.13.3 Seikagaku Corporation Orthobiologics Introduction
    • 10.13.4 Seikagaku Corporation Revenue in Orthobiologics Business (2015-2020)
    • 10.13.5 Seikagaku Corporation Recent Development
  • 13.14 RTI Surgical, Inc.
    • 10.14.1 RTI Surgical, Inc. Company Details
    • 10.14.2 RTI Surgical, Inc. Business Overview and Its Total Revenue
    • 10.14.3 RTI Surgical, Inc. Orthobiologics Introduction
    • 10.14.4 RTI Surgical, Inc. Revenue in Orthobiologics Business (2015-2020)
    • 10.14.5 RTI Surgical, Inc. Recent Development
  • 13.15 Heraeus Holding GmbH
    • 10.15.1 Heraeus Holding GmbH Company Details
    • 10.15.2 Heraeus Holding GmbH Business Overview and Its Total Revenue
    • 10.15.3 Heraeus Holding GmbH Orthobiologics Introduction
    • 10.15.4 Heraeus Holding GmbH Revenue in Orthobiologics Business (2015-2020)
    • 10.15.5 Heraeus Holding GmbH Recent Development
  • 13.16 Fidia Pharma USA Inc.
    • 10.16.1 Fidia Pharma USA Inc. Company Details
    • 10.16.2 Fidia Pharma USA Inc. Business Overview and Its Total Revenue
    • 10.16.3 Fidia Pharma USA Inc. Orthobiologics Introduction
    • 10.16.4 Fidia Pharma USA Inc. Revenue in Orthobiologics Business (2015-2020)
    • 10.16.5 Fidia Pharma USA Inc. Recent Development
  • 13.17 TRB Chemedica International SA
    • 10.17.1 TRB Chemedica International SA Company Details
    • 10.17.2 TRB Chemedica International SA Business Overview and Its Total Revenue
    • 10.17.3 TRB Chemedica International SA Orthobiologics Introduction
    • 10.17.4 TRB Chemedica International SA Revenue in Orthobiologics Business (2015-2020)
    • 10.17.5 TRB Chemedica International SA Recent Development
  • 13.18 Allosource
    • 10.18.1 Allosource Company Details
    • 10.18.2 Allosource Business Overview and Its Total Revenue
    • 10.18.3 Allosource Orthobiologics Introduction
    • 10.18.4 Allosource Revenue in Orthobiologics Business (2015-2020)
    • 10.18.5 Allosource Recent Development
  • 13.19 Musculoskeletal Transplant Foundation, Inc.
    • 10.19.1 Musculoskeletal Transplant Foundation, Inc. Company Details
    • 10.19.2 Musculoskeletal Transplant Foundation, Inc. Business Overview and Its Total Revenue
    • 10.19.3 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Introduction
    • 10.19.4 Musculoskeletal Transplant Foundation, Inc. Revenue in Orthobiologics Business (2015-2020)
    • 10.19.5 Musculoskeletal Transplant Foundation, Inc. Recent Development
  • 13.20 Ito
    • 10.20.1 Ito Company Details
    • 10.20.2 Ito Business Overview and Its Total Revenue
    • 10.20.3 Ito Orthobiologics Introduction
    • 10.20.4 Ito Revenue in Orthobiologics Business (2015-2020)
    • 10.20.5 Ito Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Orthobiologics. Industry analysis & Market Report on COVID-19 Impact on Global Orthobiologics is a syndicated market report, published as COVID-19 Impact on Global Orthobiologics Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Orthobiologics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,108.30
    4,662.45
    6,216.60
    3,623.10
    5,434.65
    7,246.20
    596,427.00
    894,640.50
    1,192,854.00
    325,338.00
    488,007.00
    650,676.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report